Clinical Trials Browser

Phase 1 × Advanced Malignancies × Nivolumab × Clear all

NCT03158272 2020-12-21

A Study of Cabiralzumab Given by Itself or With Nivolumab in Advanced Cancer or Cancer That Has Spread

Phase 1 Completed

19 enrolled 26 charts

Advanced Malignancies